Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
61,964,717
-
Share change
-
-1,368,942
-
Total reported value
-
$3,079,267,072
-
Put/Call ratio
-
10%
-
Price per share
-
$49.82
-
Number of holders
-
277
-
Value change
-
-$55,499,493
-
Number of buys
-
134
-
Number of sells
-
134
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q1 2018
As of 31 Mar 2018,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
277 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,964,717 shares.
The largest 10 holders included
BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, Bank of New York Mellon Corp, Van Berkom & Associates Inc., AQR CAPITAL MANAGEMENT LLC, and ROYAL BANK OF CANADA.
This page lists
276
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.